Karen E. Foster-Schubert, MD, MPH
Disclosures: I/we have no financial relationships to report.
KAREN EMILY FOSTER

KAREN EMILY FOSTER-SCHUBERT

 

Curriculum Vitae

University of Washington

Veterans Affairs Puget Sound Health Care System

Endocrinology (111), 1660 South Columbian Way

Seattle, WA  98108

(206) 277-6230

kfoster@u.washington.edu

 

 

 

Personal Data

Born August 15, 1971 East Lansing, Michigan

 

Education

Wellesley College, Wellesley MA

BA, Biological Sciences, June 1993

Johns Hopkins University School of Medicine, Baltimore MD

MD, June 1998

University of Washington School of Public Health and Community Medicine, Seattle WA

MS (Epidemiology), June 2010

 

Postgraduate Training

University of California San Francisco, San Francisco CA

  • Internship in Internal Medicine (Categorical Program), July 1998 – June 1999
  • Residency in Internal Medicine (PRIME Program), July 1999 – June 2001

 

University of Washington, Seattle WA

  • Clinical and Research Fellowship in Endocrinology, August 2001 – July 2005

 

Faculty Positions Held

University of Washington, Seattle WA

  • Acting Instructor of Internal Medicine, July 2005 – June 2007
  • Assistant Professor of Medicine, July 2007 – June 2013
  • Associate Professor of Medicine, July 2013 – Present

Fred Hutchinson Cancer Research Center, Seattle WA

  • Staff Scientist, February 2005 – July 2005
  • Visiting Fellow/Co-investigator NEW Trial, July 2005 – June 2007
  • Affiliate Investigator March 2007 – present

 

Hospital Positions Held

Veterans Affairs/Puget Sound Health Care System

  • Attending Physician, July 2005 – present
  • Director, Weight Disorders Program, July 2007 – present
  • Director, Clinical Operations for Endocrine Section, November 2011 – present
  • Deputy Service Line Director, Hospital and Specialty Medicine, May 2015 – present

 

Honors

Wellesley College

  • First Year Distinction, 1990
  • Phi Beta Kappa, Eta Chapter, 1992
  • Sigma Xi, 1993
  • Magna cum laude with Departmental Honors, 1993

Johns Hopkins University School of Medicine

  • Chairperson, Medical Student Society, Johns Hopkins University School of Medicine, 1997  
  • Alpha Omega Alpha, Johns Hopkins University School of Medicine, 1998

University of Washington School of Medicine

  • Pfizer Scholars in Endocrinology, 2003
  • GlaxoSmithKline Endocrinology Scholar, 2004
  • K12 Clinical Scholar, 2005
  • The Endocrine Society/Pfizer International Award for Excellence in Published Clinical Research (award recognizing the top 4 clinical research papers in the Journal of Clinical Endocrinology and Metabolism), 2009
  • Elected Member, Fred Hutchinson/University of Washington Cancer Consortium, 2010
  • 51st Mallinckrodt Scholar, 2010
  • American Federation for Medical Research, Western Section Chair, 2012-2013
  • Election to the Western Society for Clinical Investigation, 2012

 

Licensure and Certification

2001              Washington Medical License: MD00040039 (active)

2001              American Board of Internal Medicine

2004                   American Board of Internal Medicine: Endocrinology, Diabetes, and Metabolism

2011              Advanced Cardiac Life Support

2013              Basic Life Support

 

Professional Organizations

American Federation for Medical Research

                            University of Washington Councilor 2009-2011

Western Section Chair-elect 2011 - 2012

Western Section Chair 2012 - 2013

National Council, Member 2011 2013

Western Society for Clinical Investigation, Member

American Diabetes Association, Member

Endocrine Society, Member

 

Teaching Responsibilities

Courses

2002 – 2011     Small Group Leader, second year medical student Core Course in Endocrinology, University of Washington

2006               Lecturer, Graduate Seminar in Nutritional Sciences, University of Washington

2007 2010  Small Group Leader, second year medical student course in Epidemiology, University of Washington

2007 2008              Small Group Leader, second year medical student course in Nutrition, University of Washington

2007 – present               Lecturer and member of Core Course Committee, second year medical student Core Course in Endocrinology and Nutrition, University of Washington

2009 – 2011     Lecturer, graduate student Molecular Medicine course, University of Washington

2016                   Lecturer, graduate student Evolutionary Medicine course, University of Washington

 

Trainees

2008              Primary mentor, Masters (Nutrition) Clare AbbenhardtTechnical University of Munich

20092010              Thesis Committee, Masters (Epidemiology) Marc Horton – University of Washington

20092010              Thesis Committee, PhD (Nutrition) Angela Kong – University of Washington

20102011              Thesis Committee, Masters (Nutrition) Rachel Myhre – University of Washington

2012 – 2013              Thesis Committee, Masters (Nutrition) Laura Tobias – University of Washington

20142016              Thesis Committee, PhD (Nutrition) Jessica Kuzma – University of Washington

 

 

National Responsibilities

2009                            Student and Trainee Poster Award Judge, The Endocrine Society 2009 Annual Meeting

2009 – 2013              Annual Meeting Abstract Reviewer, The Endocrine Society

2010 – 2012              Annual Meeting Abstract Reviewer, The Obesity Society

2011                            Reviewer, American Diabetes Association Clinical Research Grant Program

2011 – 2013              National Council Member, American Federation for Medical Research

2012                            Early Career Reviewer, Clinical and Integrative Diabetes and Obesity (CIDO) Study Section,

                                            National Institutes of Health

 

Local Responsibilities

2007 – 2011              Chair, Adipose Biology Collaborative Group, Transdisciplinary Research on Energetics of

Cancer (“TREC”)

2009 – present              Physician Champion, VA PSHCS MOVE! Program

2012 – present              Member, VA Diabetes Committee

2013 – present               Member, VA Physician Compensation Panel

2014 – present              Member, Fellowship Clinical Competency Review Committee

2015 – present              Primary Reviewer-School of Medicine, ITHS TL1 Training Program Selection Committee

 

 

Research Funding

None

 

Publications (Chronological Order)

  1. Shi GP, Webb AC, Foster KE, Knoll JH, Lemere CA, Munger JS, Chapman HA.  Human cathepsin S: chromosomal localization, gene structure, and tissue distribution.  J Biol Chem  264, 11530-6 (1994).
  2. Zambon A, Deeb SS, Bensadoun A, Foster KE, Brunzell JD.  In vivo evidence of a role for hepatic lipase in human apoB-containing lipoprotein metabolism, independent of its lipolytic activity.  J Lipid Res 41, 2094-9 (2000).
  3. Cummings DE, Clement, K, Purnell JQ, Vaisse C, Foster KE, Frayo RS, Schwartz MW, Basdevant A, Weigle DS.  Elevated plasma ghrelin levels in Prader-Willi Syndrome.  Nature Med 8, 643-644 (2002).
  4. Cummings DE, Foster KE.   Ghrelin-leptin tango in body-weight regulation. Gastroenterology 124, 1532-1544 (2003).
  5. Cummings DE, Overduin J, Foster-Schubert KE.  Gastric bypass for obesity: mechanisms of weight loss and diabetes resolution.  J Clin Endo Metab  89, 2608-2615 (2004).
  6. Foster-Schubert KE, McTiernan A, Frayo RS, Schwartz RS, Rajan KB, Yasui Y, Tworoger SS, Cummings DE.  Exercise-induced weight loss increases human plasma ghrelin levels.  J Clin Endo Metab 90, 820-825 (2005).
  7. Cummings DE, Overduin J, Foster-Schubert KE.  Roles for ghrelin in the regulation of appetite and body weight.  Curr Opin Endo Diab  12, 72-79 (2005).
  8. Cummings DE, Foster-Schubert KE, Overduin J.  Ghrelin and energy balance: focus on current controversies.  Curr Drug Tar  6, 153-69 (2005).
  9. Cummings DE, Overduin J, Shannon MH, Foster-Schubert KE.  Hormonal Mechanisms of Weight Loss and Diabetes Resolution after Bariatric Surgery.  Surg Obes Rel Dis 1, 356-388 (2005)
  10. Foster-Schubert KE, Cummings DE.  Emerging therapeutic strategies for obesity.  Endocr Rev 27, 779-93 (2006)
  11. Littman AJ, Vittielo MV, Foster-Schubert K, Ulrich CM, Tworoger SS, Potter JD, Weigle DS, McTiernan A.  Sleep, ghrelin, leptin, and changes in body weight during a 1-year moderate-intensity physical activity intervention.  Int J Obesity 31, 466-75 (2007)
  12. Cummings DE, Overduin J, Foster-Schubert KE, Carlson M.  Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery.  Surg Obes Relat Dis 3, 109-15 (2007). PMC2702249
  13. Foster-Schubert KE*, Hawkins V*, Chubak J, Sorensen B, Ulrich CM, Stancyzk FZ, Plymate S, Stanford JL, White E, Potter JD, McTiernan A.  Effect of exercise on serum sex hormones in men: a 12-month randomized clinical trial.  Med Sci Sport Ex 40, 223-33 (2008).

*Co-first authors

  1. Schur EA, Callahan HS, Cummings DE, Foster-Schubert KE.  Association of cognitive restraint with ghrelin, leptin, and insulin levels in subjects who are not weight-reduced.  Phys Behav 93, 706-12 (2008).
  2. Foster-Schubert KE, Overduin J, Prudhom CE, Liu J, Callahan HS, Gaylinn BD, Thorner MO, Cummings DE.  Acyl and total ghrelin are suppressed strongly by ingested proteins, weakly by lipids, and biphasically by carbohydrates.  J Clin Endo Metab 93, 1971-9 (2008). PMC2386677
  3. Campbell KL, Campbell PT, Ulrich CM, Wener MW, Alfano CM, Foster-Schubert KE, Rudolph RE, Potter JD, McTiernan A.  No reduction in C-reactive protein following a 12-month randomized controlled trial of exercise in men and women. Cancer Epi Bio Prev 17, 1714-8 (2008).   PMC2493470
  4. Campbell KL, Makar KW, Kratz M, Foster-Schubert KE, McTiernan A, Ulrich CM.  A pilot study of sampling subcutaneous adipose tissue to examine biomarkers of cancer risk. Cancer Prev Res 2, 37-42 (2009) PMC2785801
  5. Paramsothy P, Lin YS, Kernic MA, Foster-Schubert KEWeight gain between pregnancies increases the risk of cesarean delivery among women with a history of gestational diabetes.  Ob Gyn 113, 817-23 (2009) PMC2743407
  6. Kong A, Neuhouser ML, Xiao L, Ulrich CM, McTiernan A, Foster-Schubert KE.  Higher habitual intake of dietary fat and carbohydrates are associated with lower leptin and higher ghrelin concentrations in overweight and obese postmenopausal women with elevated insulin levels.  Nutr Res 29, 768-76 (2009).  PMC2784426
  7. Baker LD, Frank LL, Foster-Schubert KE, Green PS, Wilkinson CW, McTiernan A, Plymate SR, Fishel MA, Watson GS, Cholerton BA, Duncan GE, Craft S.  Effects of aerobic exercise on mild cognitive impairment: a controlled trialArch Neurol. 67, 71-79 (2010).
  8. Prudom C,  Liu J, Patrie J, Gaylinn BD, Foster-Schubert KE, Cummings DE, Thorner MO, Geysen HM.  Comparison of competitive radioimmunoassays and two-site sandwich assays for the measurement and interpretation of plasma ghrelin levels.  J Clin Endo Metab 95, 2351-8 (2010).
  9. Hooper LE, Foster-Schubert KE, McTiernan A, Weigle DS, Sorensen B, Ulrich CM.  Frequent intentional weight loss is associated with higher ghrelin and lower glucose and androgen levels in postmenopausal women.  Nutr Res, 30, 163-7 (2010).
  10. Baker LD, Frank LL, Foster-Schubert KE, Green PS, Wilkinson CW, McTiernan A, Cholerton BA, Plymate SR, Fishel MA, Watson GS, Duncan GE, Mehta PD, Craft S.  Aerobic exercise improves cognition for older adults with glucose intolerance , a risk factor for Alzheimer’s disease.  J Alz Dis 22, 569-79 (2010).
  11. Foster-Schubert KE.  Hypoglycemia complicating bariatric surgery, incidence and mechanism.  Curr Op Endo Diab Obes, 18:129-33 (2011).
  12. Imayama I, Alfano CM, Cadmus L, Wang C, Xiao L, Duggan C, Campbell KL, Foster-Schubert KE, McTiernan A.  Effects of 12-month exercise on health-related quality of life: a randomized controlled trial. Prev Med, 52:344-51 (2011).
  13. Mason C,  Xiao L, Imayama I, Duggan CR, Bain C, Foster-Schubert KE, Kong A, Campbell KL, Wang CY,  Neuhouser ML, Li L, Jeffery R, Robien K, Alfano CM, Blackburn GL, McTiernan A.  Effects of weight loss on serum vitamin D in postmenopausal women. Am J Clin Nutr, 94:95-103 (2011).
  14. Mason C, Foster-Schubert KE, Imayama I, Kong A, Xiao L, Bain CE, Campbell KL, Wang CY, Duggan CR, Ulrich CM, Alfano CM, Blackburn GL, McTiernan A. Dietary weight loss and exercise effects on insulin resistance in postmenopausal women. Am J Prev Med, 41:366-75 (2011).
  15. Imayama I, Alfano CM, Kong A, Foster-Schubert KE, Bain CE, Xiao L, Duggan C, Wang CY, Campbell KL, Blackburn GL, McTiernan A.  Dietary weight loss and exercise interventions effects on quality of life in overweight/obese postmenopausal women: a randomized controlled trial. Int J Behav Nutr Phys Act 8, 118 (2011).
  16. Kong A, Beresford SAA, Alfano CM, Neuhouser ML, Foster-Schubert KE, Johnson DB, Duggan C, Wang CY, Xiao L, Bain CE, McTiernan A.  Associations between snacking and weight loss and nutrient intake among postmenopausal overweight-to-obese women in a dietary weight loss intervention.  J Amer Diet Assoc, 111:1898-903 (2011).
  17. Campbell KL, Foster-Schubert KE, Alfano CM, Cadmus L, Xiao L, Duggan CR, Irwin ML, Ulrich CM, McTiernan A.   Injuries in sedentary individuals enrolled in a 1-year randomized controlled exercise trial.  J Phys Act Health 9, 198-207 (2012).
  18. Imayama I, Ulrich CM, Alfano CM, Wang C, Xiao L, Wener MH, Campbell KL, Duggan C, Foster-Schubert KE, Kong A, Mason CE, Wang CY, Blackburn GL, Bain CE, Thompson HJ, McTiernan A. Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. Canc Res 72, 2314-26 (2012).
  19. Foster-Schubert KE, Alfano CM, Duggan CR, Xiao L, Campbell KL, Kong A, Bain C, Wang CY, Blackburn G, McTiernan A.  Effect of exercise and diet, alone or combined, on weight and body composition in overweight-to-obese postmenopausal women.  Obesity 20, 1628-38 (2012).
  20. Kong A, Beresford SA, Imayama I, Duggan C, Alfano CM, Foster-Schubert KE, Neuhouser ML, Johnson DB, Wang CY, Xiao L, Bain CE, McTiernan A. Adoption of diet-related self-monitoring behaviors varies by race/ethnicity, education, and baseline binge eating score among overweight-to-obese postmenopausal women in a 12-month dietary weight loss intervention.  Nutr Res 32, 260-5 (2012).
  21. Campbell KL, Foster-Schubert KE, Alfano CM, Wang CC, Wang CY,  Dugan CR, Mason C, Imayama I, Kong A, Xiao L, Bain CE, Blakcburn GL, Stanzyk FZ, McTiernan A.  Reduced-calorie dietary weight loss, exercise, and sex hormones in postmenopausal women: a randomized controlled trial.  J Clin Oncol 30, 2314-26 (2012).
  22. Kong A, Beresford SA, Alfano CM, Foster-Schubert KE, Neuhouser ML, Johnson DB, Duggan C, Wang CY, Xiao L, Jeffery RW, Bain CE, McTiernan A. Self-monitoring and eating-related behaviors are associated with 12-month weight loss in postmenopausal overweight-to-obese women.  J Acad Nutr Diet 112, 1428-35 (2012).
  23. Hagman DK, Kuzma JN, Larson I, Foster-Schubert KE, Kuan LY, Cignarella A, Geamanu E, Makar KW, Gottlieb JR, Kratz M.  Characterizing and quantifying leukocyte populations in human adipose tissue: impact of enzymatic tissue processing.  J Immunol Methods 386, 50-9 (2012).
  24. Imayama I, Alfano C, Mason CE, Wang C, Xiao L, Duggan C, Campbell K, Foster-Schubert K, Wang CY, McTiernan A.  Exercise adherence, cardiopulmonary fitness, and anthropometric changes improve exercise self-efficacy and health-related quality of life. J Phys Act Health 10, 676-89 (2013).
  25. Mason C, Foster-Schubert KE, Imayama I, Xiao L, Kong A, Campbell KL, Duggan CR, Wang CY,  Alfano CM, Ulrich CM, Blackburn GL, McTiernan A. History of weight cycling does not impede future weight loss or metabolic improvements in postmenopausal women.  Metabolism 62,127-36 (2013).
  26. Mason C, Xiao L, Imayama I, Duggan CR, Foster-Schubert KE, Kong A,  Campbell KL, Wang CY, Villasenor A, Neuhouser ML,  Alfano CM, Blackburn GL, McTiernan A.  Influence of diet, exercise, and serum vitamin D on sarcopenia in post-menopausal women.  Med Sci Sport Ex 45,607-14 (2013).
  27. Foster-Schubert KE*, Campbell KL*, Makar KW, Kratz M, Hagman D, Schur EA, Habermann N, Horton M, Abbenhardt C, Kuan LY, Xiao L, Davison J, Morgan M, Wang CY, Duggan C, McTiernan A, Ulrich CM.  Gene expression changes in adipose tissue with diet and/or exerciseinduced weight loss.  Cancer Prev Res 6, 217-31 (2013).

*Co-first authors

  1. Abbenhardt C, McTiernan A, Alfano CM, Wener MH, Campbell KL, Duggan C, Foster-Schubert KE, Kong A, Toriola AT, Potter JD, Mason CE, Xiao L, Blackburn GL, Bain C, Ulrich CM.  Effects of individual and combined dietary weight loss and exercise interventions in postmenopausal women on adiponectin and leptin levels. J Intern Med 274, 163-75 (2013).
  2. Mason C, Xiao L, Duggan CR, Imayama I, Foster-Schubert KE, Kong A, Campbell KL, Wang CY, Alfano CM, Blackburn GL, Pollack M, McTiernan A. Effects of Dietary Weight Loss and Exercise on Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 in Postmenopausal Women. CEBP 22, 1457-63 (2013).
  3. Mason C, Risques RA, Xiao L, Duggan CR, Imayama I, Campbell KL, Kong A, Foster-Schubert KE,  Wang CY,  Alfano CM,  Blackburn GL, Rabinovitch PS, McTiernan A. Independent and combined effects of dietary weight loss and exercise on leukocyte telomere length in postmenopausal women.  Obesity 21, E549-54 (2013).
  4. Imayama I, Alfano C, Mason CE, Wang C, Duggan C, Campbell K, Kong A, Foster-Schubert K, Blackburn GL, Wang CY, McTiernan A.  Weight and metabolic effects of dietary weight loss and exercise interventions in postmenopausal antidepressant users and non-users: a randomized controlled trial. Prev Med 57, 525-32 (2013).
  5. Cadmus-Bertram LA, Irwin M, Alfano C, Campbell K, Duggan C, Foster-Schubert K, Wang CY, McTiernan A.  Predicting adherence of adults to a 12-month exercise intervention.  J Phys Act Health 11, 1304-12 (2014).
  6. Springer AM, Foster-Schubert K, Morton GJ, Schur EA.  Is there evidence that estrogen therapy promotes weight maintenance via effects on leptin?  Menopause 21, 424-32 (2014).
  7. Morton GJ, Kaiyala KJ, Foster-Schubert KE, Cummings DE, Schwartz MW.  Carbohydrate feeding dissociates the post-prandial FGF-19 response from circulating bile acids in humans.  J Clin Endo Metab 99, E241-5 (2014).
  8. Lee JT, Pamir N, Liu NC, Kirk EA, Averill MM, Becker L, Larson I, Hagman DK, Foster-Schubert KE, van Yserloo B, Bornfeldt K, LeBoeuf R, Kratz M, Heinecke J.  Macrophage metalloelastase (MMP12) regulates adipose tissue expansion, insulin sensitivity, and the expression of inducible nitric oxide synthase.  Endocrinology 155, 3409-20 (2014).
  9. Mason C, Xiao L, Imayama I, Duggan CR, Campbell KL, Kong A, Wang CY, Alfano CM, Blackburn GL, McTiernan A*, Foster-Schubert KE*.The effects of separate and combined dietary weight loss and exercise on fasting ghrelin concentrations in overweight and obese women: a randomized controlled trial.  Clin Endo 82, 369-76 (2015).

*Co-senior authors

  1. Habermann N, Makar KW, Abbenhardt C, Xiao L, Wang CY, Utsugi HK, Alfano CM, Campbell KL, Duggan C, Foster-Schubert KE, Mason CE, Imayama I, Blackburn GL, Potter JD, McTiernan A, Ulrich CM. No effect of caloric restriction or exercise on radiation repair capacity.  Med Sci Sports Exerc 47, 896-94 (2015).
  2. Kuzma JN, Cromer G, Hagman DK, Breymeyer KL, Roth CL, Foster-Schubert KE, Holte SE, Callahan HS, Weigle DS, Kratz, M.  No difference in ad libitum energy intake in healthy men and women consuming beverages sweetened with fructose, glucose, of high-fructose corn syrup: a randomized trial. Am J Clin Nutr, 102,1373-80 (2015).
  3. Cummings DE, Arteburn DE, Westbrook EO, Kuzma JN, Stewart SD, Chan CP, Bock SN, Landers JT, Kratz M, Foster-Schubert KE, Flum DR. Gastric bypass surgery vs. intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomized controlled trial. Diabetologia 59, 945-53 (2016).
  4. Kratz M, Hagman DK, Kuzma JN, Foster-Schubert KE, Chan CP, Devlin AR, Stewart S, van Yserloo B, Westbrook EO, Arteburn DE, Flum DR, Cummings DE. Improvements in glycemic control after gastric bypass occur despite persistent adipose tissue inflammation. Obesity 24, 1438-45 (2016).
  5. Kuzma JN, Cromer G, Hagman DK, Breymeyer KL, Bates P, Roth CL, Foster-Schubert KE, Holte SE, Weigle DS, Kratz, M.  No differential effect of beverages sweetened with fructose, high-fructose corn syrup, or glucose on systemic and adipose tissues inflammation in healthy individuals: a randomized controlled feeding trial. Am J Clin Nutr 104, 306-14 (2016).
  6. Duggan C, Tapsoba JD, Wang CY, Campbell KL, Foster-Schubert KE, Gross M, McTiernan A. Dietary weight loss, exercise, and oxidative stress in post-menopausal women: a randomized controlled trial.  Cancer Prev Res 11, 835-43 (2016).
  7. Hagman D, Larson I, Kuzma JN, Cromer G,  Makar K, Rubinow KB, Foster-Schubert KE, van Yserloo B, Billing PS, Landerholm RW, Crouthamel M, Flum DR, Cummings DE, Kratz M. The short-term and long-term effects of bariatric/metabolic surgery on subcutaneous adipose tissue inflammation in humans.  Submitted, Metabolism (9/2016)

 

 

Book Chapters

Cummings DE, Foster-Schubert KE, Carlson MJ, Shannon MH, Overduin J.  Possible Hormonal Mechanisms Mediating the Effects of Bariatric Surgery.  In Pitombo C (ed), Clinical and Physiological Aspects of Bariatric Surgery, McGraw-Hill, New York, NY (2006).

 

Abstracts

Foster KE, Cummings DE, Frayo RS, Rajan B, McTiernan A.  Changes in human plasma ghrelin and leptin levels correlate negatively with each other during aerobic exercise training.  Poster P3-438, The Endocrine Society 84th Annual Meeting (2002).

Foster KE, Cummings DE, Frayo RS, Rajan B, McTiernan A.  Changes in human plasma ghrelin and leptin levels correlate negatively with each other during aerobic exercise training.  J Invest Med 50, 18A (2002).

Kletter GB, Cemeroglu AP, Foster KE, Frayo RS, Cummings DE.  Serum ghrelin concentrations after an overnight fast in children and adolescents: a cross-sectional study.  Oral Session, The Endocrine Society 84th Annual Meeting (2002).

Foster-Schubert KE, Cummings DE.  Bioactive and total human plasma ghrelin levels are suppressed similarly to one another by equicaloric beverages of different macronutrients.  Oral Session, American Federation for Medical Research Annual Western Section Regional Meeting (2004). Endocrinology Scholar Award Recipient.

Foster-Schubert KE, Weigle DS, Frayo RS, Callahan HS, Cummings DE.  Lipids suppress plasma ghrelin levels less effectively than do carbohydrates or proteins.  Poster P1-348, The Endocrine Society 86th Annual Meeting (2004).

Littman AJ, Vittielo MV, Foster-Schubert K, Ulrich CM, Tworoger SS, Potter JD, Weigle DS, McTiernan A.  Sleep, ghrelin, leptin, and changes in body weight during a 1-year moderate-intensity physical activity intervention.  Poster, International Congress on Physical Activity and Public Health (2006).

Foster-Schubert KE, Gilbert ML, Sweet I, Cummings DE.  Ghrelin Decreases Insulin Secretion from Isolated Islets, Without Affecting Oxygen Consumption or Cytochrome C Reduction: Evidence for an “Anti-Incretin” Action.  Oral Session OR-360, The American Diabetes Association 66th Annual Meeting, (2006).

Campbell KL, Makar KW, Kratz M, Foster-Schubert KE, McTiernan A, Ulrich CM.   Examination of potential biomarkers of cancer risk in subcutaneous adipose tissue in postmenopausal women:  A feasibility pilot study. Poster, FASEB Summer Research Conference: Energy Balance, Body Fat and Disease (2007).

Bain C, Duggan C, Foster-Schubert KE, Campbell KL, McTiernan A.  Recruitment for a “Nutrition and Exercise for Women” (NEW) intervention trial.  Oral Session, The American College of Sports Medicine 56th Annual Meeting (2009).

Kong A, Foster-Schubert KE, Blackburn G, Beresford S, Duggan C, Alfano C, Wang CY, McTiernan A.  Self-monitoring and eating behavior predictors of 6-month weight loss in postmenopausal overweight/obese women in a lifestyle behavior change trial.  Poster Session, The Obesity Society 27th Annual Meeting (2009).

Foster-Schubert KE, Alfano C, Duggan C, Wang CY, Blackburn G, McTiernan A.  Effect of diet, exercise, or combined diet-and-exercise on weight and body composition among overweight to obese post-menopausal women.  Oral Session, The Obesity Society 27th Annual Meeting (2009).

Kong A, Beresford S, Foster-Schubert KE, Duggan C, Alfano C, McTiernan A. Self-monitoring and eating behaviors associated with 12-month weight change in post-menopausal overweight/obese women in a lifestyle behavior change trial.  Poster Session, The Society of Behavioral Medicine 31st Annual Meeting (2010).

Foster-Schubert KE, Shankland EG, Frayo RS, Kushmerick M, Conley K, Cummings DE.  Measurement of molecular determinants of body weight regulation in the human brain using magnetic resonance spectroscopy.  Oral Session, American Federation for Medical Research Annual Western Section Regional Meeting (2011).

Kong A, Beresford SA, Alfano CM, Foster-Schubert KE, Neuhouser ML, Johnson DB, Duggan CR, Wang CY, Xiao L, Bain CE,  McTiernan A. Associations between snacking and weight loss and nutrient intake among postmenopausal overweight to obese women in a dietary weight loss intervention.  Poster Session, The Society of Behavioral Medicine 32nd Annual Meeting (2011).

Purnell JQ, Goodpaser BH, Kelley DE, Staten M, Lowery J, Ng JM, Foster-Schubert KE, Prigeon RL, Johnson G, Wahed A, Cummings DE, Havel P, Courcoulas AP, Wolfe B.  Increased islet cell secretory capacity after gastric bypass in patients with T2DM but not controls: results of the Longitudinal Assessment of Bariatric Surgery (LABS) Diabetes Substudy. Oral Session 190-OR, The American Diabetes Association 73rd Annual Meeting (2013).

Cummings DE, Arterburn DE, Westbrook EO, Kuzma JN, Stewart SD, Chan CP, Bock SN, LandersJT, Kratz M, Foster-Schubert KE, Flum DR.  Gastric bypass vs. highly intensive lifestyle and medical intervention to manage type 2 diabetes: the CROSSROADS Randomized Clinical Trial.  Oral Session T-66-OR, The Obesity Society Annual Meeting (2013).

Purnell JQ, Goodpaser BH, Kelley DE, Staten M, Foster-Schubert KE, Prigeon RL, Johnson G, Wahed A, Cummings DE, Havel P, Courcoulas AP, Flum DR, Wolfe B.  Improvements in AIRglu, SI, and DI continue 2 years after gastric bypass in patients with and without type 2 diabetes: results from the Longitudinal Assessment of Bariatric Surgery Study. Poster Session 1745-P, The American Diabetes Association 74th Annual Meeting (2014).

Purnell JQ, Johnson G, Wahed A, Prigeon RL, Goodpaser BH, Kelley DE, Staten M, Foster-Schubert KE, , Cummings DE, Flum DR, Courcoulas AP, Havel P, Wolfe B.  Islet cell secretory dysfunction characterizes failure to achieve or sustain diabetes remission after bariatric surgery. The American Diabetes Association 77th Annual Meeting (2017).

 

Invited Presentations

Obesity treatment: a team approach.  VA Women’s Health Conference, June 2002.

Obesity: Prevention, Diagnosis, Evaluation, and Treatment.  University of Washington Women’s Health Update, November 2002.

Pathophysiology of Obesity: Insights into Treatment.  Washington Association of Diabetes Educators, May 2003.

Thinner Living Through Chemistry: Pharmacotherapy for Weight Loss.  Endocrine Days Institute, October 2004.

Pharmacotherapy of Obesity: Understanding Treatment.  University of Washington Dieticians Seminar, March 2005.

Ghrelin and the Regulation of Body Weight and Glucose Homeostasis.  Diabetes Endocrinology Research Center Annual Symposium, May 2005.

Endocrine Pitfalls After Bariatric Surgery: Balancing the Outcomes.  Endocrine Days Institute, October 2006.

Managing Obesity: Approach to Evaluation and Treatment.  Annual Review of Medicine Conference, McCall ID, January 2007.

Bariatric Surgery: Possible Hormonal Mechanisms Mediating Effects on Body Weight and Glucose Homeostasis.  General Session, The American Association of Clinical Endocrinologists 16th Annual Meeting, Seattle WA, April 2007.

Metabolic Consequences of Bariatric Surgery.  Symposium Session, The Endocrine Society 89th Annual Meeting, Toronto Canada, June 2007.

Endocrine and Non-endocrine Mediators of the Therapeutic Benefit of Bariatric Surgery. Symposium Session, the 10th Annual Rachmiel Levine Diabetes and Obesity Symposium, Las Vegas NV, March 2010.

Managing Obesity: Approach to Treatment in 2010.  Novo Nordisk Preceptorship, Seattle WA, November 2010.

Managing Obesity: Approach to Evaluation and Treatment.  What’s New In Medicine (CME Conference), Kennewick WA, September 2011.

Current Understanding About the Science and Medical Therapies for Obesity.  Diabetes Update for Primary Care Providers (CME Conference).  Seattle WA, February 2012.

State of the Art Medical Treatment for Diabetes.  Symposium Session, The American Transplant Congress13th Annual Meeting, Seattle WA, May 2013.

State of the Art Obesity Treatment in 2013. University of Washington School of Medicine Grand Rounds, Seattle WA, October 2013.

Obesity update: Practical Recommendations for Medical and Surgical Therapy Diabetes Update for Primary Care Providers (CME Conference).  Seattle WA, January 2014.

Obesity update: Practical Recommendations for Medical and Surgical Therapy.  Women’s Health Update (CME Conference).  Seattle WA, March 2014.

Obesity: Approach to Evaluation and Treatment.  Zoobiquity 2014 (CME Conference).  Seattle WA, November 2014

Thyroid Disease in WomenWomen’s Health Update (CME Conference).  Seattle WA, March 2015.

Obesity update for 2016 Diabetes Update for Primary Care Providers (CME Conference).  Seattle WA, March 2016.

Diabetes in 2016. 3-Part Lectureship Series (CME Sessions) for the Alaska Federal Healthcare Partnership.  Anchorage, Fairbanks, and Kodiak, AK June 6-9 2016.

Thyroid Nodules: a Practical UpdateWomen’s Health Update (CME Conference).  Seattle WA, March 2017.

 

 

 

 

 

                            1